Last month, researchers at Ohio State University published a study in the Journal of Alternative Complimentary Medicine on the effect of EMPowerplus on people with Child-Onset Bipolar Spectrum Disorder. The results of the study are encouraging.
Researchers tracked the depression and mania levels of 7 child participants using the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present Episode-Depression Rating Scale and the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present Episode-Mania Rating Scale, respectively.
What the researchers discovered is that by the end of the 8-week, open pilot study, mean depression levels among participants had dropped 37% and mean mania levels had dropped almost in half.
This is encouraging news. While the sample is undoubtedly small, it reminds us of our roots in finding a way to address bipolar and it joins a growing body of evidence that shows the effectiveness of EMPowerplus in treating mood disorders.
We look forward to sharing more research news in the near future.
Did you like this post? Subscribe to our bi-weekly newsletter to stay up to date on new posts.